Nexgel (NXGL) Cash from Investing Activities (2020 - 2025)
Nexgel (NXGL) posted Cash from Investing Activities of -$40000.0 for Q4 2025, down 400.0% on a QoQ basis from -$8000.0 in Q3 2025, and up 36.51% year-over-year from -$29302.3 in Q4 2024.
Nexgel (NXGL) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Nexgel's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$40000.0 for Q4 2025.
- Quarterly Cash from Investing Activities rose 36.51% year-over-year to -$40000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$119000.0 (up 84.65% YoY) and the FY2025 annual result came in at -$68000.0, up 91.23% from the prior year.
- Cash from Investing Activities was -$40000.0 for Q4 2025 at Nexgel, down from -$8000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.1 million in Q2 2023 and bottomed at -$5.4 million in Q2 2022.
- A 5-year average of -$139437.5 and a median of -$51500.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities slumped 26600.0% — and 2022, when it surged 290.91%.
- Nexgel's Cash from Investing Activities stood at $121000.0 in 2021, then jumped by 290.91% to $473000.0 in 2022, then sank by 157.72% to -$273000.0 in 2023, then surged by 76.92% to -$63000.0 in 2024, then soared by 36.51% to -$40000.0 in 2025.
- Business Quant data shows NXGL's Cash from Investing Activities at -$40000.0 in Q4 2025, -$8000.0 in Q3 2025, and -$63000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Nexgel | 3.43 Mn | 1.63 Mn | 819,000.00 | -40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Dec 31, 2024 | -63,000.00 |
| Dec 31, 2024 | -63,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Dec 31, 2023 | -273,000.00 |
| Dec 31, 2023 | -273,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 4.12 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Mar 31, 2023 | 397,000.00 |
| Mar 31, 2023 | 397,000.00 |